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The	  extracellular	  matrix	   (ECM)-­‐biomimetic	   fibrillar	   structure	  of	  platelet	   lysate	   (PL)	  gels	  along	  with	   its	  enriched	  milieu	  of	  
biomolecules	   has	   drawn	   significant	   interest	   in	   regenerative	   medicine	   applications.	   However,	   PL-­‐based	   gels	   have	   poor	  
structural	   stability	   which	   severely	   limits	   its	   performance	   as	   a	   bioinstructive	   biomaterial.	   Here,	   rod-­‐shaped	   cellulose	  
nanocrystals	  (CNC)	  are	  used	  as	  a	  novel	  approach	  to	  modulate	  the	  physical	  and	  biochemical	  microenvironment	  of	  PL	  gels	  
enabling	  their	  effective	  use	  as	  injectable	  human-­‐based	  cell	  scaffolds	  with	  a	  level	  of	  biomimicry	  that	  is	  difficult	  to	  recreate	  
with	  synthetic	  biomaterials.	  The	  incorporation	  of	  CNC	  (0	  to	  0.61	  wt.%)	  into	  the	  PL	  fibrillar	  network	  during	  the	  coagulation	  
cascade	  leads	  to	  decreased	  fiber	  branching,	  increased	  interfiber	  porosity	  (from	  66	  to	  83%)	  and	  modulate	  fiber	  (from	  1.4	  ±	  
0.7	   to	   27	   ±	   12	   kPa)	   and	   bulk	   hydrogel	   (from	   18	   ±	   4	   to	   1256	   ±	   	   82	   Pa)	   mechanical	   properties.	   As	   result	   of	   these	  
physicochemical	  alterations,	  nanocomposite	  PL	  hydrogels	  resist	  to	  the	  typical	  extensive	  clot	  retraction	  (from	  76	  ±	  1	  to	  24	  ±	  	  
3	   at	   Day	   7)	   and	   show	   favored	   retention	   of	   PL	   bioactive	  molecules.	   The	   feedback	   of	   these	   cues	   on	   the	   fate	   of	   human	  
adipose-­‐derived	  stem	  cells	   is	  evaluated,	   showing	  how	   it	   can	  be	  explored	   to	  modulate	   the	  commitment	  of	  encapsulated	  
stem	  cells	  toward	  different	  genetic	  phenotypes	  without	  the	  need	  for	  additional	  external	  biological	  stimuli.	  These	  fibrillar	  
nanocomposite	   hydrogels	   allow	   therefore	   to	   explore	   the	   outstanding	   biological	   properties	   of	   human-­‐based	   PL	   as	   an	  
efficient	  engineered	  ECM	  which	  can	  be	  tailored	  to	  trigger	  specific	  regenerative	  pathways	  in	  minimal	  invasive	  strategies.	  
Introduction	  
Blood	   components	   orchestrate	   the	   highly	   complex	  
microenvironment	   present	   in	   wound	   healing	   by	   providing	   a	   wide	  
range	   of	   biological,	   chemical	   and	   scaffold-­‐forming	   structural	  
elements1,	  2.	  In	  particular,	  platelet-­‐rich	  blood	  derivatives	  contain	  an	  
enriched	  milieu	  of	   growth	   factors	   (GFs),	   cytokines,	   and	   temporary	  
extracellular	   matrix	   (ECM)	   precursors	   (e.g.	   fibrinogen	   and	  
vitronectin)	   that	   have	   shown	   to	   influence	   stem	   cell	   behavior3-­‐6.	  
Among	  them,	  platelet	  lysate	  (PL)	   is	  particularly	  interesting	  because	  
it	  shows	  a	  comparatively	  lower	  batch-­‐to-­‐batch	  variability	  due	  to	  its	  
preparation	   method	   based	   on	   platelet	   disruption	   instead	   of	  
activation	   with	   calcium	   or/and	   thrombin	   (e.g.	   platelet-­‐rich	   fibrin),	  
which	  clearly	  contributes	  to	  standardization	  of	  formulations7-­‐10,	  and	  
because	   it	   hardly	   forms	   a	   spontaneous	   gel	   due	   to	   the	   removal	   of	  
clot	   and	   platelet	   debris	   during	   its	   preparation	   that	   allows	   an	   easy	  
further	  processing10.	  
In	   clinical	   settings,	   the	   delivery	   of	   platelet-­‐rich	   blood	  
derivatives	  relies	  on	  their	  direct	   injection	  and	  further	  spontaneous	  
platelet	  activation	  upon	  contact	  with	  the	  native	  collagen	  tissue11,	  12,	  
or	   on	   the	   induction	   of	   the	   coagulation	   cascade	   prior	   to	   their	  
injection	  by	  the	  addition	  of	  thrombin	  and/or	  calcium	  to	  be	  used	  as	  a	  
fibrin-­‐based	  scaffold13.	   Interestingly,	  the	  produced	  fibrin	  scaffold	   is	  
organized	   into	   a	   ECM	  mimetic	   fibrillar	   network	   that	   contains	   key	  
cell	   adhesion	   binding	   motifs,	   which	   promote	   an	   efficient	   tissue	  
healing14.	  Despite	  their	  rapid	  translation	  into	  clinical	  applications	  for	  
the	   treatment	   of	   numerous	   conditions,	   particularly	   of	   the	  
musculoskeletal	   system3,	   several	   pre-­‐clinical	   studies	   and	   clinical	  
trials	   have	   continuously	   shown	   contradictory	   therapeutic	  
outcomes15,	  16.	  Among	  the	  several	  limitations	  that	  can	  be	  identified	  
to	   justify	   these	   results,	   there	   is	   the	   lack	   of	   well-­‐designed	   clinical	  
trials,	   the	   poor	   characterization	   of	   blood	   derivatives	   samples	   and	  
the	   lack	   of	   control	   over	   the	   delivery	   mechanisms	   of	   multiple	  
signalling	   biomolecules10.	   Moreover,	   current	   natural	   fibrillar	   gel	  
scaffolds	   solely	   based	   on	   blood	   derivatives	   components	   exhibit	  
limited	   ability	   to	   retain	   and	   protect	   biological	   active	   biomolecules	  
from	  degradation17,	  have	  extremely	  low	  mechanical	  properties	  and	  
structural	   stability18,	   and	   show	   a	   high	   contractile	   effect	   (∼75%	  
reduction	   in	  gel	   volume)	  upon	  cell	  encapsulation,	   severely	   limiting	  
their	  potential	  as	  cell	  carriers	  and	  modulators	  of	  wound	  healing19.	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The	   reinforcement	   of	   low	   strength	   matrices	   generated	   by	  
chemically	  or	  physically	  crosslinking	  natural	  and	  synthetic	  polymers	  
with	   nanomaterials	   is	   being	   explored	   as	   tissue	   engineering	   and	  
regenerative	   (TERM)	   strategies	   to	   produce	   a	   new	   generation	   of	  
nanocomposite	  hydrogels	  with	  added	  functionalities	  (e.g.	  electrical	  
or	   magnetic	   responsiveness)20,	   21,	   as	   well	   as	   to	   modulate	   their	  
mechanical	   and/or	   biological	   properties,	   or	   to	   trigger	   specific	  
cellular	   responses22.	   In	   this	   sense,	  we	  and	  others	  have	  been	  using	  
cellulose	   nanocrystals	   (CNC),	   i.e.	   rod-­‐shaped	   nanoparticles	  
produced	   from	   cellulose	   fibers,	   as	   natural-­‐based	   nanofillers	   to	  
improve	   the	  mechanical,	   structural	   and	   cell	   supporting	   properties	  
of	   soft	   hydrogel	   matrices23-­‐25.	   The	   outstanding	   strength	   and	  
stiffness,	   high	  aspect	   ratio,	   convenient	   surface	   chemistry	   and	  high	  
biocompatibility	  of	  CNC,	  are	  some	  of	  the	  properties	  that	  make	  them	  
an	   appealing	   alternative	   to	   other	   typical	   reinforcing	   nanofillers.	  
Additionally,	   the	   presence	   of	   sulfate	   groups	   on	   CNC	   surface	  
resulting	   from	   their	   typical	   production	  method	   (based	   on	   sulfuric	  
acid	  hydrolysis)	  might	  potentially	   allow	  an	  efficient	  binding	  of	  GFs	  
through	   specific	   and	   reversible	   electrostatic	   interactions.	   This	  
process	   would	   mimic	   the	   natural	   stabilization	   of	   GFs	   by	   sulfated	  
glycosaminoglycans	   (GAGs)	   present	   in	   the	   ECM	   that	   are	   known	   to	  
regulate	   their	   spatio-­‐temporal	   presentation	   and	   signaling	  
mechanisms	  in	  native	  tissues26,	  27.	  In	  fact,	  it	  has	  been	  demonstrated	  
that	  soluble	  cellulose	  sulfate	  derivatives	  with	  structural	  similarities	  
to	   heparin,	   an	   highly	   sulfated	   GAG,	   establish	   specific	   interactions	  
with	  growth	  factors,	  namely	  BMP-­‐2	  and	  FGF-­‐2	  28-­‐30,	  suggesting	  that	  
the	  sulfate	  groups	  on	  CNC	  surface	  might	  play	  a	  relevant	  role	  on	  the	  
active	  modulations	  of	  the	  hydrogel	  biological	  microenvironment.	  In	  
addition,	  CNC	   reinforcement	  might	  enable	   to	   tune	   the	  mechanical	  
properties	   of	   fibrin	   network	   at	   the	   fiber	   level	   in	   order	   to	   stabilize	  
the	  natural	  fibrillar	  nature	  of	  blood	  derivatives	  and	  to	  use	  them	  as	  
injectable	  biomimetic	  scaffolding	  biomaterials.	  
In	   this	  work,	  we	   developed	   an	   injectable	   and	  multifunctional	  
nanocomposite	   fibrillar	   hydrogel	   based	   on	   the	   induction	   of	   PL	  
coagulation	  cascade	  while	  incorporating	  CNC	  modified	  with	  surface	  
aldehyde	   groups	   (see	   supplementary	   information	   Figure	   S1).	  
Conceptually,	   CNC	   will	   be	   entrapped	   in	   the	   fibrils’	   structure	   and	  
simultaneously	   crosslinked	   through	   reversible	   Schiff	   base	   bonds	  
established	   with	   the	   amine	   groups	   of	   PL	   proteins.	   Thus,	   it	   is	  
anticipated	  that	  this	  simple	  one-­‐pot	  polymerization	  and	  crosslinking	  
method	   potentiates	   its	   fast	   in	   situ	   gelation	   and	   structural	  
stabilization	   after	   extrusion	   while	   allowing	   their	   administration	  
using	   minimal	   invasive	   strategies.	   We	   hypothesize	   that	   the	  
incorporation	   of	   CNC	   will	   not	   only	   have	   a	   positive	   impact	   on	   the	  
microstructural	  and	  mechanical	  properties	  of	  the	  fibrillar	  structure,	  
but	  will	  also	  enable	  to	  modulate	  the	  biochemical	  microenvironment	  
generated	   within	   the	   hydrogel.	   It	   is	   expected	   that	   these	   dynamic	  
alterations	   on	   the	   physicochemical	   properties	   of	   PL-­‐based	   fibrillar	  
hydrogels	   can	   influence	   the	   biological	   behavior	   of	   encapsulated	  




Hydrogels	   production.	   Stock	   solutions	   of	   PL	   and	   a-­‐CNC	   were	  
produced	  and	  fully	  characterized	  (for	  details	  on	  the	  preparation	  and	  
characterization,	  see	  supporting	  information).	  Double-­‐barrel	  syringe	  
L-­‐system	   (1:1	   from	   Medmix,	   Switzerland)	   with	   a	   static	   mixer	   tip	  
(Medmix,	  Switzerland)	  was	  used	  to	  produce	  the	  hydrogels.	  Barrel	  A	  
was	   filled	   with	   PL	   (67.6	   mg	   mL-­‐1	   of	   total	   protein)	   composed	   of	  
albumin,	  growth	  factors,	  cytokines	  and	  structural	  proteins	  (such	  as	  
fibrinogen,	   vitronectin	   and	   fibronectin).	   Barrel	  B	  was	   composed	  of	  
thrombin	   from	   human	   plasma	   (2	   U	   mL-­‐1,	   Sigma-­‐Aldrich,	   USA),	  
calcium	  (10	  mM,	  Sigma-­‐Aldrich,	  USA)	  and	  a-­‐CNC	  water	  dispersions	  
corresponding	   to	   0,	   2.3,	   4.5,	   9	   and	   18	   wt.%	   of	   PL	   total	   protein	  
content.	   The	   precursor	   solutions	   were	   then	   hand	   extruded	   into	  
cylindrical	   acrylic	  molds	   (10	  mm	  diameter	   x	  6	  mm	  height).	   Finally,	  
the	   samples	   were	   incubated	   during	   2	   hours	   at	   37	   °C	   to	   allow	   PL	  
matrix	  polymerization	  and	  crosslinking.	  The	  final	  hydrogels	  were	  all	  
composed	  of	  50	  vol.%	  of	  PL	  and	  were	  named	  according	  to	  their	  a-­‐
CNC	   concentrations:	   0	   wt.%	   (PL-­‐CNC	   0),	   0.15	   wt.%	   (PL-­‐CNC	   0.15),	  
0.31	  wt.%	   (PL-­‐CNC	   0.31),	   0.45	  wt.%	   (PL-­‐CNC	   0.45),	   and	   0.61	  wt.%	  
(PL-­‐CNC	  0.61).	  
	  
Characterization	   of	   nanocomposite	   hydrogel	   microstructure.	  
Hydrogels	  were	  produced	  as	  described	  above	  and	  then	  fixed	  in	  2%	  
glutaraldehyde	   (Merck,	   Germany)	   for	   2	   hours.	   After	   fixation,	  
samples	   were	   solvent	   exchanged	   from	   water	   to	   ethanol	   (ethanol	  
gradient	   from	   25,	   50,	   75	   and	   99.9	   vol.%)	   for	   4	   hours	   and	   then	  
critical	  point	  dried	  with	  CO2.	  After	  immersion	  in	  liquid	  nitrogen,	  the	  
samples	  were	  freeze-­‐fractured	  to	  expose	  their	  inner	  structures,	  and	  
sputter	  coated	   (30	  seconds	  at	  20	  mA,	  Cressington)	  with	  gold	  prior	  
observation	   in	  a	   scanning	  electron	  microscope	   (JSM-­‐6010LV,	   JEOL,	  
Japan).	   Based	   on	   the	   typical	   fibrinogen	   concentration	   range	   in	   PL	  
(454	  ±	  75	  µg	  mL-­‐1)31,	  9	  µg	  of	  Alexa	  Fluor®	  488	  conjugated	  fibrinogen	  
from	  human	  plasma	  (Thermo	  Fisher	  Scientific,	  USA)	  were	  added	  to	  
each	   1	   mL	   of	   PL	   solution	   (barrel	   A)	   for	   visualization	   of	   the	   fibrin	  
network	  by	  confocal	  microscopy.	  For	  this	  analysis,	  PL-­‐CNC	  hydrogels	  
were	  produced	  in	  PDMS	  molds	  (9	  mm	  diameter	  x	  2	  mm	  height)	  on	  a	  
glass	   coverslip	  and	  observed	  on	  a	   laser	   scanning	   confocal	   TCS	  SP8	  
(Leica	   Microsystems,	   Germany)	   with	   a	   63x	   immersion	   objective.	  
Twenty	   micrometer	   thick	   Z-­‐stacks	   were	   imaged	   at	   every	   0.2	   µm	  
beginning	   5	   µm	   above	   the	   coverslip	   surface.	   PL-­‐CNC	   hydrogels	  
porosity	  was	   calculated	   using	   ImageJ	   software	   (National	   Institutes	  
of	  Health,	  USA).	  Z-­‐stacks	  obtained	  from	  confocal	  fluorescence	  were	  
subdivided	   into	   4	   µm	   Z-­‐stacks	   (20	   frames)	   and	   the	   corresponding	  
projected	   images	   were	   filtered	   with	   Gaussian	   Blur	   filter	   (Sigma	  
radius	   1),	   background	   subtracted	   (pixel	   15)	   and	   sharpen.	   From	  
these	   filtered	   images,	   a	   thresholding	   mask	   was	   set	   to	   the	   mean	  
pixel	   intensity	   of	   the	   image	   and	   the	   image	   was	   inverted	   to	  
determine	   the	   percent	   area	   that	   was	   not	   considered	   as	   a	   fiber.	  
Then,	  the	  porosity	  area	  was	  determined	  indirectly.	  
	  
Polymerization	   kinetics	   and	   mechanical	   properties	   of	  
nanocomposite	   hydrogels.	   A	   Kinexus	   Prot	   Rheometer	   (Malvern	  
Instruments,	  United	  Kingdom)	  with	  a	  parallel-­‐plate	  geometry	  and	  a	  
hood	   for	   temperature	   control	   (37	   °C)	   was	   used	   to	   measure	   the	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viscoelastic	  properties	  of	  PL-­‐CNC	  hydrogels.	  Time-­‐sweep	  tests	  were	  
applied	   to	   study	   polymerization	   kinetics	   of	   the	   different	  
formulations.	   Immediately	   after	   dispensing	   320	   µL	   of	   extruded	  
solution	   on	   the	   bottom	   plate,	   a	   20	   mm	   diameter	   top	   plate	   was	  
lowered	  to	  a	  final	  gap	  of	  1	  mm	  (parallel	  plate	  set	  up).	  A	  thin	  film	  of	  
mineral	   oil	  was	  poured	  over	   the	   exposed	   surface	   to	   reduce	  water	  
evaporation.	  This	  time	  point	  was	  defined	  as	  the	  starting	  time	  (t=0).	  
Time-­‐sweep	  assays	  were	  performed	  at	  a	  strain	  amplitude	  of	  1%	  and	  
frequency	   of	   1	   Hz,	   and	   storage	   modulus	   values	   were	   monitored	  
continuously	   at	   10	   seconds	   intervals.	   In	   strain	   and	   frequency-­‐
sweeps	  tests,	  hydrogels	  were	  formulated	  as	  described	  above	  and	  an	  
8	  mm	  top	  plate	  was	  used	  (parallel	  plate	  set	  up).	  A	  fixed	  frequency	  
of	  1	  Hz	  was	  applied	  with	  a	   strain	  amplitude	   from	  0.01	   to	  100%	  to	  
establish	  the	  linear	  region.	  At	  a	  fixed	  strain	  amplitude	  value	  (0.5%)	  
selected	   within	   linear	   viscoelastic	   region,	   frequency	   sweeps	   from	  
0.1	  to	  10	  Hz	  were	  performed	  to	  obtain	  the	  frequency	  dependence	  
of	   the	   storage	   modulus	   (G’)	   and	   loss	   modulus	   (G’’).	   	   All	  
measurements	   were	   performed	   in	   triplicate.	   Nanomechanical	  
properties	   of	   the	   fibrillary	   hydrogels	   were	   assessed	   by	   AFM	  
(NanoWizard	   3,	   JPK	   Instruments,	   Germany).	   Hydrogels	   were	  
prepared	  on	  a	   coverslip	   sample	  holder	   (JPK	   Instruments)	  and	  kept	  
hydrated	   in	  PBS.	  Cantilevers	   (Bruker,	  MSNL-­‐10-­‐C,	  nominal	  k	  =	  0.01	  
N	  m-­‐1)	  was	  pre-­‐calibrated	  in	  PBS	  using	  a	  contact-­‐based	  method	  (on	  
a	   glass	   surface).	   Height	   and	  moduli	   images	   (256x256	   pixels)	   were	  
acquired	  over	  a	  100	  µm2	  square	  area	  of	  the	  hydrogel.	  Moduli	  were	  
calculated	   by	   fitting	   the	   results	   to	   the	   Sneddon	   Model	   using	   a	  
Poisson	   ratio	   of	   0.5.	   At	   each	   acquired	   point	   it	   was	   used	   an	  
indentation	   depth	   between	   0.5-­‐1.0	   µm.	   JPK	   SPM	   Data	   Processing	  
(JPK	  Instruments)	  were	  used	  to	  determine	  hydrogel	  (n=4)	  and	  fiber	  
(n=20)	  rigidity.	  
	  
Hydrogel	   Degradation.	   For	   degradation	   assays,	   hydrogels	   were	  
produced	  in	  a	  circular	  polypropylene	  supports	  (9	  mm	  diameter	  x	  4	  
mm	  height).	  Each	  support	  was	  pre-­‐weighted,	  and	  their	  weight	  was	  
subtracted	   to	   the	   total	   weight	   of	   the	   support	   with	   hydrogel	   to	  
obtain	  the	  hydrogel	  initial	  mass	  (Mi).	  After	  2	  hours	  of	  incubation	  at	  
37	   °C	   to	   allow	   hydrogel	   polymerization	   and	   crosslinking,	   each	  
hydrogel	   was	   incubated	   in	   1.5	   mL	   of	   PBS	   pH=7.4	   at	   37	   °C	   and	  
successively	   weighted	   at	   different	   time	   points	   to	   obtain	   the	   final	  
mass	   (Mf).	   	   The	   weight	   loss	   was	   calculated	   according	   to	   the	  
following	   Equation	   1.	   The	   results	   are	   an	   average	   of	   three	  
measurements	  obtained	  per	  formulation	  (n=4).	  	  	  Weight	  loss	   % = 	  ./0.1./ 	  x	  100	   	   	   	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  (Equation	  1)	  
	  
Growth	   factor	   release.	   Hydrogels	   were	   produced	   in	   circular	  
supports	   (V=0.4	  mL)	   as	   described	   above	   for	   hydrogel	   degradation	  
assay	  and	   incubated	   in	  0.7	  mL	  of	  cell	   culture	  medium	  at	  37	  ºC.	  At	  
different	   time	   points	   (6	   h,	   1,	   2,	   4,	   5	   days),	   the	   supernatant	   was	  
collected	   and	   replaced	   with	   fresh	   cell	   culture	   medium.	   Platelet-­‐
Derived	  Growth	  Factor-­‐BB	  (PDGF-­‐BB)	  content	  in	  the	  supernatant	  of	  
PL-­‐CNC	  0,	  0.31	  and	  0.61	  (n=5)	  was	  quantified	  using	  human	  PDGF-­‐BB	  
enzyme-­‐linked	   immunosorbent	   assay	   (ELISA)	   Development	   kit	  
(Peprotech,	   USA)	   according	   to	   the	   manufacturer’s	   instructions.	  
Furthermore,	  on	  day	  5,	  remaining	  hydrogels	  were	  disrupted	  using	  a	  
tissue	  grinder	  (Nippon	  Genetics,	  Japan)	  and	  5	  seconds	  of	  sonication	  
using	  a	   sonication	  probe.	  After	  centrifugation,	   the	  pellet	  was	  used	  
to	   detect	   PDGF-­‐BB	   by	   sodium	   dodecyl	   sulfate–polyacrylamide	   gel	  
electrophoresis	   (SDS-­‐PAGE)	   and	   Western	   Blot.	   Laemmli	   sample	  
buffer	  was	  mixed	  with	   standard	   PDGF-­‐BB	   (Peprotech,	   USA)	   at	   1:1	  
ratio,	  and	  with	  hydrogels	  pellet	  and	  PL	  at	  9:1	  ratio.	  All	  formulations	  
were	   heated	   at	   95	   °C	   for	   5	   minutes	   and	   subjected	   to	   SDS-­‐PAGE	  
using	   3%	   stacking	   and	   12.5%	   separation	   polyacrylamide	   gels	  
prepared	   according	   to	   manufacturer’s	   protocol	   (SDS	   Gel	  
Preparation	   kit,	   Sigma	   Aldrich,	   USA).	   Electrophoresis	   was	   carried	  
out	  at	  75	  V	  for	  15	  min	  and	  then	  at	  150	  V	  for	  1	  h	  (BioRad,	  USA).	  The	  
SDS-­‐PAGE	   and	   polyvinylidene	   difluoride	   membrane	   were	  
overlapped	  and	  proteins	  transferred	  at	  70	  V	  and	  350	  mA	  for	  15	  min	  
(Pierce	   Power	   station,	   Thermo	   Fisher	   Scientific,	   USA).	   5%	   milk	  
powder	  solution	  was	  used	  for	  membrane	  blocking	  for	  30	  min	  at	  RT.	  
The	  membrane	  was	  then	  incubated	  with	  1:100	  dilution	  rabbit	  anti-­‐
PDGF-­‐BB	   (Peprotech,	  USA)	   primary	   antibody	   under	  mild	  mixing	   at	  
4	  °C	  overnight.	  The	  membrane	  was	  washed	  with	  TBS-­‐T	  solution	  for	  
5	  min	  (3x)	  then	  incubated	  with	  a	  1:1000	  dilution	  of	  goat	  anti-­‐rabbit	  
IgG	  –	  alkaline	  phosphatase	   (Vector	   laboratories,	  USA)	  mixed	  at	  RT	  
for	  30	  minutes,	  before	  washing	  the	  membrane	  as	  described	  above.	  
The	   alkaline	   phosphatase	   conjugate	   substrate	   (Thermo	   Fisher	  
Scientific,	   USA)	   was	   added	   to	   the	   polyvinylidene	   difluoride	  
membrane	   until	   color	   development,	   and	   after	   water	   washing,	  
membranes	  were	  scanned.	  
	  
Cell	  isolation	  and	  encapsulation	  in	  the	  hydrogels.	  Human	  adipose-­‐
derived	  stem	  cells	  (hASCs)	  were	  obtained	  from	  lipoaspirate	  samples	  
of	   the	   abdominal	   region	   of	   patients	   undergoing	   plastic	   surgery,	  
under	   the	   scope	   of	   previously	   established	   protocols	  with	   Hospital	  
da	  Prelada	  (Porto,	  Portugal)	  with	  the	  approval	  of	  the	  Hospital	  Ethics	  
Committee	   and	   informed	   consent	   was	   obtained	   from	   all	   human	  
subjects.	   	   The	  hASCs	   isolation	  and	  stemness	  characterization	  were	  
performed	   using	   a	   previous	   optimized32	   Briefly,	   the	   lipoaspirate	  
samples	   were	   washed	   with	   PBS	   and	   1%	   antibiotic/antimycotic	  
solution	  until	   erythrocytes	   removal,	   and	   then	  digested	  with	  0.05%	  
collagenase	   Type	   I	   A	   in	   PBS	   for	   60	  minutes	   at	   37	   ºC	   under	   gentle	  
stirring.	   The	   digested	   tissue	  was	   filtered	   and	   centrifuged	   at	   800xg	  
for	   10	   minutes	   at	   4ºC	   and	   the	   supernatant	   removed.	   The	  
heterogeneous	   cell	   pellet	   was	   resuspended	   in	   α-­‐MEM	   medium	  
supplemented	  (Thermo	  Fisher	  Scientific,	  USA)	  with	  10%	  fetal	  bovine	  
serum	   (FBS)	   (Thermo	   Fisher	   Scientific,	   USA),	   and	   1%	  
antibiotic/antimycotic	   solution	   (Thermo	   Fisher	   Scientific,	   USA).	  
After	   24	   hours	   of	   incubation,	   the	   adherent	   cells	   were	   washed	  
(hASCs)	  and	  characterized	  by	   flow	  cytometry	   for	   the	  expression	  of	  
mesenchymal	   stem	   cells	  markers	   (CD45,	   CD105	   and	  CD90),	   Figure	  
S4,	   as	   previously	   reported	   to	   define	   multipotent	   mesenchymal	  
stromal	  cells33-­‐35.	  hASCs	  were	  maintained	  in	  α-­‐MEM	  supplemented	  
with	  10%	  FBS,	   and	  1%	  antibiotic/antimicotic	   solution	  at	  37	   ºC,	   5%	  
CO2.	   hASCs	   were	   loaded	   to	   PL	   solution	   (barrel	   B)	   at	   a	   density	   of	  
2x106	  cells	  per	  1	  mL	  of	  PL	   (1x106	  cells	  per	  1	  mL	  of	   final	  hydrogel),	  
then	  hydrogels	  were	  produced	  as	  described	  above.	  All	   cell	   culture	  
assays	   of	   hASCs	   encapsulated	   in	   hydrogels	   were	   performed	   using	  
culture	  media	  without	  FBS.	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Cellular	   viability	   and	   proliferation	   studies.	   Cellular	   viability	   was	  
assessed	   using	   1:500	   vol.%	   Calcein	   AM	   (Thermo	   Fisher	   Scientific,	  
USA)	  and	  1:1000	  vol.%	  propidium	   iodide	   (Thermo	  Fisher	  Scientific,	  
USA)	   for	  15	  min	  at	  37	   °C	   to	   stain	   live	  and	  dead	  cells,	   respectively.	  
Samples	   were	   washed	   with	   phosphate	   buffered	  saline	   (PBS)	   to	  
reduce	   background	   fluorescence	   and	   visualized	   using	   confocal	  
microscope	  TCS	  SP8	  (Leica	  Microsystems,	  Germany).	  The	  metabolic	  
activity	   of	   encapsulated	   hASCs	   was	   evaluated	   at	   1,	   4	   and	   7	   days	  
using	   Alamar	   Blue	   assay	   (Bio-­‐Rad,	   USA).	   Fluorescence	   readings	   of	  
Alamar	   Blue	   were	   normalized	   to	   the	   deoxyribonucleic	   acid	   (DNA)	  
content.	   For	   DNA	   quantification,	   hydrogels	   were	   sonicated	   three	  
times	   for	   10	   s	   using	   an	   ultrasound	   probe	   at	   40%	   of	   amplitude	  
output.	   Released	   DNA	   was	   quantified	   using	   Quant-­‐iT	   PicoGreen	  
dsDNA	   assay	   kit	   (Thermo	   Fisher	   Scientific,	   USA)	   following	  
manufacturer’s	  instructions.	  
	  
Cell	  morphology	  and	  matrix	  production.	  hASCs	  encapsulated	  in	  all	  
PL-­‐CNC	   hydrogels	   were	   cultured	   up	   to	   -­‐8	   days.	   Additionally,	   to	  
analyze	  cell	  morphology	  within	  the	  fibrillar	  network,	  some	  hydrogel	  
formulations	  were	  supplemented	  with	  fibrinogen-­‐FITC,	  as	  described	  
above	   for	   the	   analysis	   of	   the	   hydrogel	   microstructure.	   Hydrogels	  
were	   washed	   with	   PBS	   and	   then	   fixed	   in	   10%	   formalin	   (Thermo	  
Fisher	  Scientific,	  USA)	  for	  15	  min	  at	  RT	  and	  permeabilized	  using	  0.2	  
vol.%	   Triton-­‐X100	   (Sigma-­‐Aldrich,	   USA).	   After	   washing,	   samples	  
were	   incubated	   with	   1:200	   v/v	   rhodamine-­‐conjugated	   phalloidin	  
(Sigma-­‐Aldrich,	  USA)	  for	  10	  minutes	  and	  1:1000	  v/v	  4ʹ′,	  6-­‐diamidino-­‐
2-­‐phenylindole	  (DAPI,	  Sigma-­‐Aldrich,	  USA)	  for	  20	  minutes	  (dilutions	  
in	  PBS).	  For	  collagen	   type	   III,	   samples	  were	  blocked	  using	  3	  w/v.%	  
BSA	   and	   incubated	   with	   1:100	   v/v	   solution	   of	   specific	   primary	  
antibody	  (ab7778,	  Abcam,	  UK).	  Then,	  samples	  were	  incubated	  with	  
1:200	  v/v	  Alexa	  Fluor®	  488	  conjugated	  secondary	  antibody	  (Thermo	  
Fisher	   Scientific,	   USA).	   The	   hydrogels	   were	   observed	   under	   a	  
confocal	  microscope	   TCS	   SP8	   (Leica	  Microsystems,	   Germany).	   The	  
effect	  of	  CNC	  content	  on	  cell	  spreading	  area	  and	  cell	  axial	  ratio	  was	  
characterized	   by	   analyzing	   their	   shape	   using	   Image	   J	   software	  
object	   tools.	   Fluorescence	   confocal	   images	   were	   converted	   to	  
binary	  images	  to	  identify	  individual	  cells	  and	  a	  mean	  threshold	  was	  
used	   to	  quantify	  morphometric	   parameters.	   	   Aspect	   ratio	   and	   cell	  
area	  were	  quantified	  at	  day	  1	  for	  all	  formulations	  (n=20)	  and	  at	  day	  
3	  (n=20)	  for	  PL-­‐CNC	  0.61	  formulation.	  	  
	  
Ribonucleic	   acid	   (RNA)	   isolation	   and	   real-­‐time	   polymerase	   chain	  
reaction	  (PCR)	  analysis.	  After	  1	  and	  7	  days	  of	  cell	  culture,	  total	  RNA	  
was	   isolated	   using	   Ribozol	   (Amresco,	   USA),	   according	   to	  
manufacturer’s	  protocol.	  Total	  RNA	  was	  quantified	  at	  260	  nm	  using	  
a	  nanodrop	  spectrophotometer	  (Thermo	  Fisher	  Scientific,	  USA).	  The	  
same	   amount	   of	   RNA	   (0.2	   µg)	   was	   reverse	   transcribed	   to	  
complementary	   DNA	   (cDNA)	   according	   to	   the	   protocol	   of	   the	  
supplier	   (qScript	   cDNA	   Synthesis	   Kit,	   Quanta	   Biosciences,	   USA).	  
Aliquots	   of	   each	   cDNA	   sample	   were	   frozen	   (-­‐20	   °C)	   until	   the	   PCR	  
reactions	  were	   carried	   out.	   Real-­‐time	  PCR	  was	   performed	   for	   two	  
reference	   genes,	   glyceraldehyde-­‐3-­‐phosphate	   dehydrogenase	  
(GAPDH)	   and	   β-­‐Actin	   and	   target	   genes	   (Table	   S1).	   	   Real-­‐time	   PCR	  
was	   performed	   in	   a	   thermocycler	   (Realplex,	   Eppendorf,	   Germany)	  
using	   SYBR	   green	   detection	   (Quanta	   Biosciences,	   USA).	   Each	  
reaction	   contained	   7	   μl	   of	   master	   mix	   (Perfecta	   SYBR	   Green	  
FastMix,	   Quanta	   Biosciences,	   USA),	   the	   sense	   and	   the	   antisense	  
specific	  primers	  (0.5	  μM)	  and	  cDNA	  sample	  (3	  μl)	   in	  a	  final	  volume	  
of	   10	   μl.	   The	   amplification	   program	   consisted	   of	   a	   pre-­‐incubation	  
step	   for	   denaturation	   of	   the	   template	   cDNA	   (5	   minutes	   95	   °C),	  
followed	  by	  45	  cycles	  consisting	  of	  a	  denaturation	  step	  (10	  seconds	  
95	  °C),	  an	  annealing	  step	  (10	  seconds	  60	  °C)	  and	  an	  extension	  step	  
(10	  seconds	  72	  °C).	  After	  each	  cycle,	  fluorescence	  was	  measured	  at	  
72	   °C.	  A	  negative	   control	  without	   cDNA	   template	  was	   run	   in	   each	  
assay.	  All	   samples	  were	  normalized	  by	   the	  geometric	  mean	  of	   the	  
expression	   levels	   of	   β-­‐Actin	   and	   GAPDH	   and	   fold	   changes	   were	  
related	  to	  the	  control	  groups	  using	  the	  equation	  2	  adapted	  from36.	  	  𝑟𝑎𝑡𝑖𝑜 = :;<=>?;@AB	  ;<=>?;	  (D?<E	  FGE;=GH	  –	  J<DBH?):=?L?=?EF?@AB	  =?L?=?EF?	  (D?<E	  FGE;=GH	  –	  J<DBH?)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (Equation	  
2)	  
Cp	  is	  the	  crossing	  point	  of	  the	  reaction	  amplification	  curve	  and	  E	  is	  
the	  efficiency	   from	   the	  given	   slopes	  using	   serial	  dilutions.	   Stability	  
of	   reference	   genes	   was	   calculated	   using	   a	   statistical	   tool	  
(BestKeeper	   software,	   Technical	   University	   of	   Munich,	  
Weihenstephan,	  Germany)37.	  	  
Alkaline	   phosphatase	   activity.	   After	   9	   days	   of	   culture,	   hydrogels	  
were	   washed	   with	   PBS	   and	   cells	   were	   lysed	   in	   water	   using	   two	  
freeze-­‐thaw	   cycles,	   mechanical	   disruption	   and	   ultrasounds.	   ALP	  
activity	   from	   25	   μl	   of	   sample	   was	   quantified	   by	   measuring	   the	  
cleavage	   of	   100	   μl	   of	   p-­‐Nitrophenyl	   phosphate	   (pNPP;	   Sigma-­‐
Aldrich,	  USA)	   in	   a	   soluble	   yellow	  end	  product	   that	   absorbs	   at	   405	  
nm.	   In	   parallel,	   a	   standard	   curve	   with	   calf	   intestinal	   ALP	   (Roche,	  
Germany)	  was	  constructed.	  Readings	  were	  normalized	   to	   the	  DNA	  
content,	  determined	  as	  described	  above.	  
Statistical	   Analysis.	   The	   statistical	   analysis	   of	   data	  was	   performed	  
using	   GraphPad	   PRISM	   v	   7.0.	   One-­‐way	   or	   two-­‐way	   analysis	   of	  
variance	  (ANOVA)	  was	  used	  to	  analyze	  experimental	  data,	  followed	  
by	   Tukey	   posthoc	   test	   for	   multiple	   comparisons.	   Statistical	  
significance	  was	   set	   to	   p	   <	   0.05.	   Results	   are	   presented	   as	  mean	   ±	  
standard	  deviation.	  
Results	  &	  Discussion	  
	  
CNC	   content	   tuned	   the	   microstructural	   and	   physicochemical	  
properties	   of	   fibrillar	   nanocomposite	   hydrogels.	   Fibrin	   gels	   result	  
from	   the	   self-­‐assembly	   of	   fibrinogen	   induced	   by	   thrombin	   and/or	  
calcium	  ions,	  being	  widely	  explored	  as	  a	  multifunctional	  framework	  
for	   cell	   adhesion,	   proliferation	   and	   differentiation13.	   In	   our	   study,	  
the	   nanocomposite	   hydrogel	   was	   extruded	   using	   a	   double-­‐barrel	  
syringe	  (ratio	  1:1).	  Barrel	  A	  was	  filled	  with	  PL	  (67.6	  mg.mL-­‐1	  of	  total	  
protein	  content)	  and	  barrel	  B	  was	  composed	  of	   thrombin,	  calcium	  
(CaCl2)	  and	  a-­‐CNC	  water	  dispersions.	  Herein,	  the	  concentrations	  of	  
thrombin	   and	   calcium	   were	   pre-­‐optimized	   to	   maximize	   the	  
hydrogel	   mechanical	   properties	   and	   stability	   (see	   supplementary	  
information	   Fig.	   S2).	   The	   final	   concentration	  of	   1	  U.mL-­‐1	   thrombin	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and	   5	  mM	  CaCl2	   produced	   relatively	   fast	   gelling	   and	   stable	   PL	   gel	  
clots	  and	  was	  therefore	  chosen	  as	  the	  control	  condition	  (PL-­‐CNC	  0).	  
CNC	   were	   then	   incorporated	   at	   varying	   concentrations	   (0.31-­‐1.22	  
wt.%)	   to	   obtain	   nanocomposite	   fibrillar	   hydrogels	   with	   the	   final	  
concentration	  of	  0.15-­‐0.61	  wt.%	  (PL-­‐CNC	  0.15-­‐0.61)	  (Scheme	  1).	  	  	  
The	   impact	   of	   CNC	   on	   individual	   fiber	   characteristics	   and	  
hydrogel	   network	   microstructure	   were	   analyzed	   by	   confocal	   and	  
scanning	   electron	   microscopy	   (SEM),	   Figure	   1.	   For	   confocal	  
microscopy	   analysis,	   9	   µg	   of	   fluorescently	   labeled	   fibrinogen	   was	  
added	  to	  1	  mL	  of	  PL	  solution	  in	  order	  to	  enable	  the	  observation	  of	  
the	   fiber	   structure.	   Similarly	   to	   the	   previously	   reported	  
characteristic	   of	   other	   PL	   based	   hydrogel31,	   PL-­‐CNC	   0	   exhibited	   a	  
dense	  meshwork	   of	   highly	   branched	   and	   randomly	   oriented	   fibrin	  
fibers	   with	   low	   interfiber	   space	   (Figure	   1-­‐A	   and	   D).	   The	  
incorporation	  of	  CNC	   led	   to	  an	  overall	  decrease	  of	   fiber	  branching	  
and	  gradual	  increase	  of	  interfiber	  porosity	  from	  66%	  in	  PL-­‐CNC	  0	  up	  
to	  83%	  in	  PL-­‐CNC	  0.61	  (Figure	  1-­‐B).	  Interestingly,	  the	  same	  trend	  is	  
also	  observed	  in	  fiber	  diameter,	  with	  PL-­‐CNC	  0	  having	  relatively	  thin	  
fibers	  (152	  ±	  54	  nm)	  that	  gradually	  become	  thicker	  with	  increasing	  
CNC	  incorporation	  in	  nanocomposite	  hydrogels	  (259	  ±	  85	  nm	  in	  PL-­‐
CNC	  0.61),	  Figure	  1-­‐C.	  	  
Under	   physiological	   conditions,	   fibrin	   central	   domains	   interact	  
nonconvalently	   with	   complementary	   sites	   at	   the	   end	   domains	   of	  
other	  fibrin	  molecules	  and	  assemble	  into	  two-­‐stranded	  protofibrils.	  
Upon	   growing	   to	   a	   sufficient	   length,	   protofibrils	   start	   to	   laterally	  
associate38-­‐40.	   In	   our	   study,	   the	   observed	   physical	   differences	  
demonstrate	   that	   CNC	   have	   an	   impact	   on	   the	   fibrinogen	   self-­‐
assembly	  and	  fibrin	  network	  architecture	  mechanisms.	  Considering	  
CNC	  dimensions	  	  (3.5	  ±	  1.3	  nm	  of	  height	  and	  168	  ±	  60	  nm	  of	  length,	  
determined	   by	   atomic	   force	   microscopy),	   it	   is	   plausible	   that	   CNC	  
might	  get	  entrapped	  along	  the	  fibers	  during	  the	  lateral	  aggregation	  
of	  fibrin	  protofibrils,	  and	  at	  the	  same	  time	  introduce	  intermolecular	  
covalent	  bonds	   that	  might	   further	  promote	   this	  process.	  Since	   the	  
aldehyde	   groups	   on	   CNC’s	   surface	   allow	   them	   to	   act	   as	   covalent	  
protein	  crosslinkers,	   it	  potentiate	  the	  natural	  fiber	  packing,	  playing	  
a	   similar	   role	   as	   Factor	   XIIIa,	   which	   forms	   crosslinks	   between	   the	  
protofibrils	  within	  each	  fiber	  and	  later	  complete	  the	  maturation	  of	  
the	  network	   structure41,	   42.	   Consequently,	   fibers	   gradually	  become	  
more	   densely	   packed	   with	   increasing	   CNC	   content,	   ultimately	  
resulting	   in	   thicker	   and	   straighter	   fibers	   as	   observed	   in	   the	  
nanocomposite	  hydrogels.	  	  
The	  structural	  differences	   induced	  by	  the	  incorporation	  of	  CNC	  
in	   PL	   hydrogels	   led	   to	   significant	   changes	   in	   their	   physical	  
properties.	   Figure	   2	   shows	   the	  mechanical	   properties	   at	   different	  
length	   scales	   (bulk	   and	   nanoscale),	   degradation	   behavior	   and	  
platelet-­‐derived	   GF-­‐BB	   (PDGF-­‐BB)	   release	   profile	   of	   hydrogels	  
prepared	   with	   different	   CNC	   concentrations	   (0	   to	   0.61	   wt.%).	  
Concerning	  the	  bulk	  mechanical	  behavior,	  no	  significant	  differences	  
could	  be	  detected	  for	  gelation	  time,	  with	  all	  formulations	  showing	  a	  
solid-­‐like	  behavior	   (G´	  >	  G´´)	   right	  after	  extrusion	   (t=0)	   rather	   than	  
behaving	   as	   a	   fluid	   (Figure	   2-­‐A).	   Nevertheless,	   increasing	   CNC	  
loadings	   gradually	   increased	   the	   storage	   modulus	   (G’)	   plateau,	  
although	   at	   the	   highest	   CNC	   content	   it	   could	   be	   noticed	   a	   slower	  
progression	   that	   did	   not	   fully	   cease	   after	   1.5	   hour.	   This	   behavior	  
finds	  some	  parallelism	  with	  the	  slow	  increase	  of	  stiffness	  observed	  
in	  blood	  clots	  along	  the	  time,	  a	  process	  governed	  by	  Factor	  XIIIa41,	  
supporting	   our	   hypothesis	   on	   the	   effect	   of	   CNC	   over	   the	  
mechanisms	  of	  fiber	  formation.	  In	  general,	  all	  formulations	  showed	  
a	  relatively	  fast	  polymerization	  and	  crosslinking,	  reaching	  a	  near	  G’	  
plateau	  within	  5	  to	  10	  min	  of	   incubation,	  demonstrating	  therefore	  
its	   potential	   to	   be	   used	   as	   an	   injectable	   and	   in	   situ	   crosslinkable	  
formulation.	  	  
Measurements	   within	   the	   hydrogel	   linear	   viscoelastic	   region	  
demonstrated	   that	   bulk	   hydrogel	   stiffness	   significantly	   increased	  
compared	  to	  the	  neat	  PL	  matrix,	  even	  at	  the	  low	  CNC	  loadings	  used	  
here	  (Figure	  2-­‐B).	  While	  PL-­‐CNC	  0	  had	  a	  low	  storage	  modulus	  (18	  ±	  
4	  Pa),	  confirming	  the	  soft	  nature	  of	  these	  gels	  also	  reported	  in	  other	  
studies	   (G’	   lower	   than	   10	   Pa	   for	   similar	   PL	   formulations)31,	   for	  
formulations	   containing	   CNC,	   G'	   increases	   by	   up	   to	   an	   impressive	  
two	  orders	   of	  magnitude	   (1256	   ±	   82	   Pa	   in	   PL-­‐CNC	  0.61).	  We	  next	  
explored	   the	   nanoscale	   mechanical	   properties	   of	   the	  
nanocomposite	  hydrogels	   to	  better	  understand	  and	  anticipate	   the	  
possible	   interactions	   with	   cells	   at	   this	   size	   scale	   (Fig.	   2-­‐C	   and	   D).	  
High	   CNC	   loadings	   increased	   hydrogel	   rigidity,	   as	   observed	   in	   the	  
bulk	   rheological	   characterization	   (Figure	   2-­‐C).	   Strikingly,	   PL-­‐CNC	  0,	  
0.31	   and	   0.61	   fibers	   achieved	   elasticity	   values	   (Young’s	   modulus)	  
close	  to	  brain	  (0.1-­‐1	  kPa),	  muscle	  (8-­‐17	  kPa)	  and	  collagenous	  bone	  
(25-­‐40	  kPa)	  tissues,	  respectively43,	  44,	  Figure	  2-­‐D.	  However,	  whereas	  
the	  rigidity	  of	  PL-­‐CNC	  0	  hydrogel	  (1.8	  ±	  0.03	  kPa)	  was	  similar	  to	  the	  
values	  obtained	  along	  its	  fibers	  (1.4	  ±	  0.7	  kPa)	  as	  demonstrated	  by	  
the	  homogeneous	  elastic	  modulus	  along	  these	  samples	  (Figure	  2-­‐C),	  
increase	   of	   CNC	   loadings	   is	   accompanied	   by	   an	   increase	   of	   fiber	  
thickness	   (topography	   images)	   and	   sample	   heterogeneity	   (moduli	  
images),	  showing	  significant	  difference	  between	  fiber	  (27	  ±	  12	  kPa)	  
and	   hydrogel	   moduli	   (12	   ±	   7	   kPa).	   Interestingly,	   it	   has	   been	  
previously	   demonstrated	   that	   the	   fiber	   elastic	   modulus	   strongly	  
decreases	   with	   increasing	   fiber	   diameter	   in	   either	   plasma	   or	  
purified	  fibrinogen	  clots39.	   It	  has	  been	  suggested	  that	  this	  negative	  
diameter	  dependence	  of	  the	  modulus	  is	  correlated	  with	  a	  decrease	  
of	   cross-­‐sectional	   density	   of	   bonds	  within	   fibrin	   fibers	   with	   larger	  
diameters.	  Moreover,	  is	  has	  also	  been	  demonstrated	  that	  clots	  with	  
thinner	   fibers	  have	  higher	  whole-­‐clot	  moduli	  due	   to	   the	   increased	  
modulus	   of	   the	   single	   fibers	   and	   network	   branch	   points39,	   45.	  
Remarkably,	   the	   mechanical	   properties	   of	   our	   nanocomposite	  
hydrogels	  show	  a	  reverse	  trend.	  Increasing	  CNC	  loadings	  leads	  to:	  1)	  
thicker	   fibers	   with	   higher	   stiffness;	   2)	   hydrogels	   with	   higher	  
interfiber	   space	   (porosity),	   and	   thus	   lower	   branch	   points,	   with	  
higher	   bulk	   stiffness.	   Therefore,	   these	   results	   further	   support	   the	  
hypothesis	  that	  CNC	  might	  indeed	  increase	  the	  crosslinking	  density	  
among	   protofibrils	   within	   the	   fibrin	   fiber	   in	   a	   process	   that	   also	  
promotes	   the	   effective	   stress	   transfer	   from	   the	   protein	  matrix	   to	  
the	   stiff	   reinforcing	   nanofiller.	   All	   these	   effects	   synergistically	  
contribute	   to	   increase	   the	   fiber	   and	   hydrogel	   stiffness	   with	   high	  
CNC	   content,	   demonstrating	   how	   the	   proposed	   strategy	  might	   be	  
used	   to	   control	   the	   physical	   properties	   of	   PL	   hydrogels	   as	  
biomaterials	  for	  TERM	  applications.	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Fibrillar	  nanocomposite	  hydrogels	  modulated	  matrix	  degradation	  
and	   the	   proteins	   release	   profile.	   Besides	   poor	   mechanical	  
properties,	  the	  use	  of	  fibrin	  based	  gels	  has	  been	  challenging	  due	  to	  
their	  low	  in	  vitro/in	  vivo	  stability13.	  	  The	  use	  of	  fibrinolysis	  inhibitors	  
such	   as	   aprotinin	   has	   been	   applied	   to	   mitigate	   this	   problem31	   46.	  
However,	   it	   has	   been	   recently	   shown	   that	   aprotinin	   impaired	  
vascular	   network	   formation	   in	   in	   vitro	   co-­‐cultures	   of	   human	  
umbilical	   vascular	   endothelial	   cells	   and	   human	   adipose-­‐derived	  
stem	  cells	   (hASCs)	  encapsulated	   in	   fibrin	  gels47,	   suggesting	   that	   its	  
use	  might	  have	  negative	   implications	   in	  general	   tissue	  engineering	  
strategies.	  Herein	  we	  did	  not	  use	  protease	  inhibitors,	  and	  therefore	  
PL-­‐CNC	  0	  hydrogels	  showed	  a	  markedly	  higher	  weight	  loss	  (95	  ±	  4%)	  
in	   comparison	   with	   PL-­‐CNC	   0.61	   (51	   ±	   7%)	   after	   7	   days	   of	  
degradation	  in	  phosphate	  buffered	  saline	  (PBS)	  (Figure	  2-­‐E)	  and	  the	  
same	   trend	   was	   observed	   on	   total	   protein	   release	   (see	  
supplementary	   information	   Figure	   S3).	   PL-­‐CNC	   0	   was	   almost	  
completely	   degraded	   over	   time,	  whereas	   PL-­‐CNC	   0.61	  maintained	  
61%	  of	  the	  hydrogel	  protein	  at	  the	  end	  of	  the	  assay,	  demonstrating	  
that	   CNC	   incorporation	   hinders	   the	   inherent	   proteolytic	  
degradation	  of	  PL	  hydrogels	  and	  could	   therefore	  be	  an	   interesting	  
alternative	  to	  the	  use	  of	  aprotinin.	  	  
Another	   important	   drawback	   associated	   with	   PL-­‐based	   gels	   is	  
the	   lack	   of	   control	   over	   dose	   and	   spatio-­‐temporal	   delivery	   of	  
specific	  platelet-­‐derived	  biomolecules	  due	  to	  the	  low	  stability	  of	  the	  
gel	   fibrillar	  matrix9,	   10.	   In	  an	   in	  vivo	  scenario,	   fibrin(ogen)	   is	  known	  
for	   its	   ability	   to	   bind	  GFs	   through	   its	   heparin-­‐binding	   domain	   and	  
uses	  this	  affinity	  based	  mechanism	  to	  control	  the	  sequestering	  and	  
subsequent	   release	   of	   signaling	   biomolecules48.	   For	   example,	  
whereas	   fibroblast	   GF-­‐2	   (FGF-­‐2)	   has	   high	   binding	   affinity	   to	  
fibrinogen	   and	   strong	   retention	   in	   the	   fibrin	  matrix,	   PDGF-­‐BB,	   the	  
major	  GF	  constituent	  of	  platelet	  releasate49,	  has	  low	  binding	  affinity	  
to	  fibrinogen	  and	  low	  retention	  in	  the	  fibrin	  matrix	  (>	  80%	  released	  
after	   one	   day	   from	   fibrin	   gels)48.	   Considering	   the	   low	   affinity	   of	  
PDGF-­‐BB	   to	   fibrin,	   we	   select	   it	   as	   a	   GF	   model	   to	   investigate	   the	  
potential	   impact	  of	  CNC	  on	  the	  sequestering	  and	  release	  profile	  of	  
signaling	   biomolecules	   from	   nanocomposite	   hydrogels.	   Strikingly,	  
whereas	  PL-­‐CNC	  0	  showed	  a	  burst	  release	  profile	  of	  PDGF-­‐BB	  within	  
the	  first	  day	  (Figure	  2-­‐F),	  a	  behavior	  also	  observed	  in	  other	  PL	  based	  
gels17,	   in	   the	   nanocomposite	   hydrogels	   its	   release	   was	   below	   the	  
detection	   limit	   of	   the	   ELISA	   assay.	   To	   guarantee	   that	   PDGF-­‐BB	  
release	  from	  the	  nanocomposite	  hydrogels	  was	  not	  detected	  do	  to	  
experimental	   inaccuracies,	   we	   qualitatively	   evaluated	   by	   western	  
blot	  the	  amount	  of	  PDGF-­‐BB	  within	  the	  remaining	  hydrogels	  at	  the	  
end	  of	  the	  assay	  (Figure	  2-­‐G).	  As	  expected,	  PDGF-­‐BB	  was	  detectable	  
in	   the	   nanocomposite	   formulations,	   indicating	   that	   this	   GF	   was	  
sequestered	  within	  the	  hydrogel	  network,	  but	  not	  in	  PL-­‐CNC	  0.	  The	  
electrostatic	   binding	   of	   PDGF-­‐BB	   (isoelectric	   point	   at	   pH	   9.39)	   on	  
the	   negatively	   charged	   CNC	   surface	   certainly	   contributes	   to	   its	  
significant	  retention	  within	  the	  nanocomposite	  hydrogels,	  although	  
other	  binding	  mechanisms	  might	  justify	  these	  results.	  Upon	  contact	  
with	   platelet-­‐derived	   biomolecules,	   a	   “hard”	   corona	   composed	   by	  
high	  affinity	  proteins	  will	  develop	  on	  CNC	  surface	  over	  time,	  which	  
might	  be	  stabilized	  by	  imine	  bonding.	  In	  theory,	  the	  recruitment	  of	  
specific	   biomolecules	   to	   the	   nanoparticle	   surface	   might	   be	  
advantageously	   exploited	   to	   modulate	   the	   protein	   corona	  
composition	   and	   consequently	   the	   biological	   identity	   of	   the	  
nanocomposite	   hydrogel	  microenvironment50.	   This	   concept	   would	  
find	  a	  parallelism	  with	  the	  events	  happening	  during	  wound	  healing,	  
where	   signaling	  molecules	   are	   released	   from	   ECM	   through	   finely-­‐
orchestrated	  mechanisms	  regulated	  by	  its	  binding	  affinity	  to	  matrix	  
components	   and	   on	   the	   action	   of	   proteases27.	   Sulfated	  
glycosaminoglycans	  (GAGs)	  in	  particular	  play	  important	  roles	  on	  the	  
regulation	  of	   their	   spatio-­‐temporal	  presentation	  within	   the	  wound	  
microenvironment51.	   Considering	   that	   majority	   of	   CNC	   surface	  
chemistry	  has	  high	  similarities	  with	  sulfated	  GAGs,	  it	  is	  plausible	  to	  
hypothesize	   that	   it	   might	   favor	   the	   dynamic	   adsorption	   of	  
biomolecules	   with	   high	   affinity	   to	   these	   polysaccharides52,	  
including,	  not	  only	  PDGF-­‐BB,	  but	   several	  other	  platelet-­‐derived	  GF	  
that	   establish	   specific	   binding	   to	   sulfated	   GAGs51.	   However,	   in	  
contrast	  to	  GAGs	   	   the	  soluble	  form	  of	  cellulose	  sulfate	  derivatives,	  
which	   are	   relatively	   flexible	   and	   predominantly	   hydrophilic	  
polymers,	   the	   surface	   chemistry	   of	   rigid	   CNC	   is	   not	   isotropic	   and	  
contains	   hydrophilic	   but	   also	   exposed	   hydrophobic	   domains	  
attributed	   to	   the	   (200)β/(220)α	   crystalline	   edge	   of	   the	   cellulosic	  
crystals,	   conferring	   them	   an	   amphiphilic	   character53.	   The	   recent	  
developments	   on	   the	   characterization	   of	   bio-­‐nano	   interfaces30,	   50	  
suggests	  that	  such	  structural	  and	  chemical	  anisotropy	  will	  certainly	  
have	  an	  important	  impact	  on	  the	  entity	  of	  the	  protein	  corona	  built	  
on	   CNC	   surface	   in	   the	   complex	   PL	   environment.	   Therefore,	   the	  
nature	   of	   the	   interactions	   establish	   between	   specific	   PL	  
biomolecules	   of	   interest	   with	   the	   CNC	   surface	   should	   be	  
systematically	  characterized	  in	  future	  studies.	  
It	   worth	   noting	   that	   the	   equilibrium	   established	   between	   the	  
imine	   bond	   and	   its	   corresponding	   precursors	   in	   aqueous	   media,	  
namely,	   carbonyls	   of	   CNC	   and	   amines	   of	   PL’s	   proteins,	   has	   a	  
dynamic	   nature.	   Imines	   can	   participate	   in	   multiple	   types	   of	  
equilibrium-­‐controlled	   reactions	   (hydrolysis,	   exchange	   or	  
metathesis)	   influenced	  by	  several	  external	   factors	   (e.g.	  precursor’s	  
concentration,	  pH	  or	  temperature)54,	  55	  which	  have	  been	  extensively	  
explored	  in	  the	  development	  of	  controlled	  drug	  delivery	  systems56-­‐
58.	  Although	  the	  carbonyls	  of	  CNC	  will	  preferentially	  react	  with	  the	  
higher	   concentrated	   proteins	   in	   the	   PL,	   e.g.	   albumin	   and	  
fibrin(ogen)10,	   it	  can	  also	  react	  with	  GFs,	  representing	  therefore	  an	  
additional	  level	  of	  control	  in	  the	  sequestration	  and	  release	  of	  these	  
bioactive	  molecules	   from	   the	  nanocomposite	   hydrogel	  matrix.	   For	  
example,	   it	   is	   know	   that	   the	   pH	   milieu	   in	   wounds	   can	   vary	   from	  
acidic	   to	   basic	   depending	   on	   several	   factors,	   including	   the	   time	  
course	  and	  wound-­‐stage	  (acid	  in	  acute	  wounds	  and	  basic	  in	  chronic	  
wounds)59.	  Therefore,	  it	  is	  likely	  that	  the	  shift	  of	  the	  imine	  reaction	  
equilibrium	   toward	   the	   precursors	   or	   the	   products	   in	   acute	   or	  
chronic	   wounds,	   respectively,	   will	   result	   in	   different	   GF	   release	  
profiles	  from	  the	  nanocomposite	  hydrogel	  matrix.	  	  	  	  	  
	  
Stem	   cells	  were	   able	   to	   sense	   and	   respond	   to	   fibrillar	   hydrogels	  
stiffness.	   As	   mentioned	   above,	   CNC	   incorporation	   improved	   PL	  
hydrogel	   mechanical	   properties	   and	   stability	   due	   to	   the	   inherent	  
CNC	  stiffness	  and	   the	   increased	  crosslinking	  density	  of	   the	   fibrillar	  
hydrogel	   network.	   Having	   fiber	   diameters	   close	   to	   collagen	   fibrils	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(100-­‐200	  nm),	  these	  biomaterials	  closely	  mimic	  the	  topography	  and	  
hierarchical	   structure	   of	   native	   ECM,	   characteristics	   that	   are	   not	  
present	   in	   the	   typical	   polymer	   hydrogel	   systems	   used	   in	   TERM	  
applications60.	  The	  geometrical	  properties	   (e.g.	  porosity,	   fiber	   like-­‐
architecture)	   of	   PL-­‐CNC	   nanocomposites	   are	   crucial	   not	   only	   to	  
allow	   sufficient	   nutrient	   and	   waste	   product	   transport61	   and	  
consequently	   enable	   cell	   survival,	   but	   also	   affect	   other	   important	  
cell	   behaviors	   such	  as	  migration62,	   63.	  Acknowledging	   that	  dynamic	  
changes	   in	   ECM	   microenvironment	   (e.g.	   mechanical	   cues	   and	  
remodeling)	   have	   been	   shown	   to	   regulate	   cell	   functions44,	   64,	   we	  
analyzed	   the	   impact	   of	   hydrogel	   features	   on	   stem	   cell	   supportive	  
properties	   using	   hASCs.	   These	   cells	   are	   harvested	   from	   adipose	  
tissue	  in	  large	  numbers	  and	  have	  been	  studied	  as	  an	  excellent	  and	  
widely	   available	   autologous	   multipotent	   cell	   source65.	   The	   facile	  
crosslinking	   process	   allowed	   hASCs	   encapsulation	   within	   the	  
hydrogel	   network,	   showing	   high	   viability	   immediately	   after	  
extrusion	   that	   was	   maintained	   in	   the	   following	   7	   days	   of	   culture	  
(Figure	  3-­‐A).	  Although	  a	  higher	  cell	  density	  was	  visible	  on	  PL-­‐CNC	  0,	  
the	  decrease	  of	  normalized	  metabolic	  activity	  indicates	  that	  this	  cell	  
number	  is	  due	  to	  the	  extensive	  retraction	  of	  fibrin	  network	  leading	  
the	  high	  cellular	  concentration	  in	  the	  gel	  volume	  (Figure	  3-­‐B).	  Upon	  
hASCs	  encapsulation,	  PL-­‐CNC	  0	  had	  a	  manifold	  densification	  of	  the	  
fibrin	   network,	   referred	   to	   as	   clot	   retraction,	   which	   led	   to	   a	  
dramatic	  75%	  reduction	  in	  hydrogel	  diameter	  (Figure	  3-­‐C	  and	  D).	  In	  
vivo,	  it	  is	  assumed	  that	  clot	  retraction	  plays	  a	  role	  in	  approximating	  
the	   edges	   of	   a	   tissue	   defect	   and	   in	   concentrating	   the	   clot	   in	   the	  
injured	   area66.	   However,	   this	   high	   contractile	   effect	   is	   undesirable	  
for	  hydrogels	   to	  be	  applied	   in	   space	   filling	  of	  wounded	  sites.	  With	  
CNC	   incorporation,	   the	   hydrogels	   showed	   a	   lower	   clot	   retraction	  
accompanied	  by	  a	  higher	  proliferative	  capacity.	  The	  produced	  fibrin	  
fiber	   network	   recapitulating	   the	   cellular-­‐ECM	   interactions	  
complexity	  and	  supporting	  cell	  adhesion	  and	  remodeling14	  is	  clearly	  
favored	  by	  CNC	  reinforcement.	  	  
Material´s	  biophysical	  cues,	  namely	  topography	  and	  mechanical	  
properties,	   are	   key	   parameters	   in	   the	   regulation	   of	   stem	   cell	  
behavior44,	   63.	  Regarding	  mechanical	  properties	   in	  particular,	   there	  
is	   an	   increasing	   body	   of	   evidence	   supporting	   the	   concept	   that	  
mesenchymal	   stem	   cells	   are	   extremely	   sensitive	   to	   tissue-­‐level	  
elasticity	   and	   that	   these	  physical	   cues	   are	   transduced	   into	   lineage	  
specification43,	   67.	   Therefore,	   considering	   the	   significantly	   different	  
physicochemical	   properties	   of	   the	   developed	   nanocomposite	  
hydrogels,	   we	   evaluated	   its	   impact	   on	   cell	   cytoskeleton	  
organization,	   spreading	   and	   gene	   expression	   as	   a	   preliminary	  
indication	  of	  stem	  cell	  preferential	  differentiation	  pathways.	  	  
In	  the	  soft	  PL	  gels,	  actin	  filaments	  were	  not	  well	  developed	  and	  
visible,	  but	  these	  progressively	  became	  longer	  and	  organized	  on	  the	  
stiffer	   nanocomposite	   hydrogels	   (Figure	   4-­‐A).	   24	   hours	   upon	  
encapsulation,	   the	  majority	  of	  hASCs	   in	  PL-­‐CNC	  0	   showed	  a	   round	  
morphology	   that	   was	   even	   more	   evident	   at	   day	   3	   (Figure	   4-­‐C),	  
mainly	  due	  to	  the	  contraction	  of	  the	  fibrin	  network	   in	  response	  to	  
the	   pulling	   forces	   exerted	   by	   cells	   during	   culture	   (Figure	   4-­‐A).	  
Conversely,	   PL-­‐CNC	   0.31	   and	   0.46	   formulations	   showed	   high	   cell	  
spreading	  area	  and	  cell	  axial	   ratio	   (Figure	  4-­‐B),	  demonstrating	  that	  
the	   nanocomposite	   fibrillar	   network	   can	   counteract	   cell	   puling	  
forces	   without	   undergoing	   extensive	   retraction.	   In	   PL-­‐CNC	   0.61	   it	  
was	   even	  possible	   to	   quantify	   these	   cellular	   parameters	   at	   a	   later	  
time	  point	  (day	  3)	  due	  to	  the	  minimal	  cellular	  overlap,	  showing	  that	  
as	   cells	   continue	   to	   proliferate,	   they	   undergo	   high	   cytoskeleton	  
elongation	   and	   present	   extended	   cell	   spreading	   area	   (Figure	   4-­‐D).	  
This	  trend	  was	  confirmed	  by	  histological	  analysis	  for	  longer	  culture	  
periods	   (14	   days),	   demonstrating	   that	   whereas	   PL-­‐CNC	   0	   show	   a	  
highly	  compact	  cellularized	  structure	  due	  to	  the	  extensive	  hydrogel	  
retraction,	   CNC-­‐loaded	   hydrogels	   promote	   cell	   spreading	   and	   the	  
formation	   of	   well-­‐developed	   cellular	   networks	   (Figure	   S5).	   To	  
evaluate	   the	   impact	   of	   these	   different	   cellular	   behaviors	   on	   ECM	  
synthesis,	  we	  further	  analyzed	  the	  deposition	  of	  collagen	  type	  III	  by	  
encapsulated	  hASCs,	  which	  is	  deposited	  during	  the	  initial	  phases	  of	  
wound	   healing	   to	   provide	   a	   provisional	   cell	   supportive	   matrix2,	  
being	   remodeled	   to	  other	   collagen	   types	   in	   later	   stages	  of	  wound	  
repair.	   Interestingly,	   cell	   encapsulated	   in	   CNC-­‐loaded	   hydrogels	  
showed	   higher	   deposition	   of	   collagen	   type	   III	   and	   with	   a	   more	  
fibrillar-­‐like	   appearance	   than	   PL-­‐CNC	   0	   hydrogels	   (Figure	   4-­‐E),	  
suggesting	   that	   those	   formulations	   favor	   the	   progressive	  
remodeling	   of	   the	   hydrogel	   3D	   space	  with	   newly	   synthesized	   cell-­‐
origin	  ECM,	  a	  factor	  that	  might	  contribute	  to	  the	  increased	  hydrogel	  
structural	   stability	   observed	   during	   cell	   culture.	   The	   marked	  
differences	   observed	   in	   cell	  morphology	   also	   feedback	   the	   role	   of	  
the	   hydrogel	   biophysical	   cues	   on	   the	   cells	   mechanotransduction	  
process,	   since	   the	   stiffer	   fibrillar	   nanocomposite	   hydrogels	  
promoted	   molecular	   mechanosensing	   mechanisms	   mediated	   by	  
integrins	  which	  are	   transduced	   into	  actin	  polymerization	  and	   focal	  
adhesion	   maturation63.	   Ultimately,	   the	   traction	   forces	   between	  
hydrogel	  matrix	  and	  cells	  can	  alter	  gene	  expression,	  and	  therefore	  
induce	   cell	   commitment	   toward	   different	   phenotypes68.	   In	   fact,	  
gene	  expression	  analysis	  revealed	  that	  on	  one	  hand,	  hASCs	  laden	  on	  
the	  softest	  PL	  CNC	  0	  hydrogels	  (2.2	  kPa)	  showed	  an	  upregulation	  of	  	  
transcription	   factors	   related	   to	   distinct	   lineages	   osteogenic69,	  
tenogenic70,	   chondrogenic71	   and	   adipogenic72),	   and	   PDGF-­‐BB,	   an	  
anti-­‐morphogenic	   marker	   (Figure	   5-­‐A).	   These	   results	   are	   in	  
agreement	  with	  the	  increasing	  use	  of	  PL	  as	  a	  prevailing	  supplement	  
for	   cell	   culture	   in	   replacement	   of	   animal	   serum,	   being	   capable	   of	  
faster	   in	   vitro	   stem	   cell	   expansion	   while	   maintaining	   their	  
stemness73-­‐75	   ,	   therefore	   suggesting	   its	   potential	   to	   repress	   cell	  
differentiation	   into	   specific	   lineages.	   The	   presence	   of	   multiple	  
cytokines	  and	  chemokines	  with	  opposite	  biological	  signaling	  roles	  in	  
PL	   formulations	   might	   contribute	   to	   explain	   these	   results	   and	  
highlight	  one	  of	  main	  difficulties	  generally	  associated	  with	   the	  use	  
of	  blood	  derivatives	  in	  regenerative	  medicine:	  the	  establishment	  of	  
rational	   cell	   stimuli	   protocols	   and	   consequently,	   therapeutic	  
strategies10.	   On	   the	   other	   hand,	   hASCs	   cultured	   on	   CNC-­‐loaded	  
hydrogels	   exhibited	   distinct	   genetic	   profiles,	   showing	   an	  
upregulation	   	   osteogenic	   and	   chondrogenic	   related	  markers	   along	  
with	   downregulation	   of	   lipoprotein	   lipase	   (LPL),	   an	   adipogenic	  
marker,	   indicating	   potential	   cell	   commitment	   toward	   different	  
lineages	  depending	  on	  CNC	  content76,	   77.	   In	  the	  stiffer	  PL-­‐CNC	  0.61	  
hydrogels,	  the	  levels	  of	  RUNX2	  increased	  over	  time	  (from	  11	  ±	  1.1%	  
at	  day	  1	  to	  20	  ±	  3.6	  %	  at	  day	  7),	  while	  the	  expression	  of	  all	  the	  other	  
studied	   transcription	   factors	   decreased.	   Furthermore,	   cells	   on	   this	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hydrogel	   formulation	   showed	   around	   10-­‐fold	   upregulation	   of	  
alkaline	  phosphatase	  (ALP)	  expression,	  confirmed	  by	  increased	  ALP	  
activity	   (Figure	   5-­‐B),	   indicating	   potential	   osteogenic	   commitment.	  
Differently,	  on	  moderately	  stiff	  PL-­‐CNC	  0.31	  hydrogels,	   from	  day	  1	  
to	  day	  7,	  hASCs	  show	  an	  increased	  expression	  of	  two	  chondrogenic	  
related	  markers	  namely,	  cartilage	  oligomeric	  matrix	  protein	  (COMP)	  
and	   SRY-­‐box	   9	   (SOX9).	   Remarkably,	   although	   the	   use	   of	   PL-­‐based	  
gels	   has	   attracted	   significant	   interest	   in	   the	   promotion	   of	  
vascularization	   in	   regenerative	   strategies	   due	   to	   their	   contents	   in	  
angiogenic	   GFs	   that	   favor	   mesenchymal	   stem	   cells	   invasion	   and	  
endothelial	   sprouting17,	   31,	   we	   observed	   that	   the	   expression	   of	  
angiogenic	   related	   genes	   such	   as	   vascular	   endothelial	   GF	   (VEGF)	  
declined	  more	   than	  one	   fold	   at	   day	   7	   in	   PL-­‐CNC	  0	   (Figure	   4-­‐A).	   In	  
contrast,	   in	   the	   moderately	   stiff	   matrices	   PL-­‐CNC	   0.31,	   the	  
expression	  of	  this	  gene	  increased	  to	  the	  levels	  of	  control	  group	  (PL-­‐
CNC	  0	  at	  day	  1).	  These	  findings	  suggest	  that,	  as	  in	  native	  ECM78,	  an	  
adequate	   physical	   and	   chemical	   environment	   capable	   of	  
sequestering	   and	   presenting	   angiogens	   to	   cell	   receptors	  might	   be	  
needed	   to	   sustain	   the	   angiogenic	   potential	   of	   PL	   over	   time.	  
Therefore,	   the	   interaction	  between	  angiogens	   and	  nanocomposite	  
hydrogel	   matrix	   and	   how	   these	   synergies	   can	   potentiate	  
vascularization	  processes	  deserve	  further	  study.	  	  
In	   summary,	   we	   developed	   a	   method	   to	   create	   injectable	  
fibrillar	  nanocomposite	  hydrogels	  based	  on	  PL	  combined	  with	  CNC	  
as	  a	  platform	  that	  allowed	  the	  use	  of	  this	  blood	  derivative	  not	  only	  
as	  a	  source	  of	  signaling	  biomolecules	  involved	  in	  wound	  healing,	  but	  
also	  as	  an	  injectable	  cell	  carrier	  biomaterial	  with	  tunable	  biophysical	  
and	  biochemical	  cues	  for	  cell	  delivery	  in	  TERM	  strategies.	  We	  have	  
demonstrated	   that	  by	   increasing	  CNC	   loading	   in	  natural	   fibrillar	  PL	  
hydrogels	   it	   is	   possible	   to	   increase	   fiber	   diameter,	   stiffness,	  
interfibrillar	   porosity,	   hinder	   the	   typical	   fast	   clot	   degradation,	   and	  
improve	   bioactive	   molecules	   sequestering,	   enabling	   therefore	   its	  
use	  as	  effective	  ECM-­‐mimetic	  biomaterials	  in	  which	  we	  can	  control	  
the	   3D	   cell	   microenvironment	   (Scheme	   2).	   The	   physical	   changes	  
occurring	   in	   the	   fibrillar	   network	   stemming	   from	   CNC	   load	   and	  
crosslinking	   led	   to	   hydrogels	   that	   do	   not	   compromise	   the	  
outstanding	   cytocompatibility	   of	   PL	   gels,	   can	   resist	   extensive	  
retraction	   upon	   3D	   cell	   culture	   and	   have	   a	   marked	   impact	   on	  
determining	   cell	   behavior.	   We	   have	   shown	   that	   cell	   cytoskeletal	  
organization	  can	  be	  easily	  manipulated	  by	  controlling	  CNC	  loadings	  
and	   these	   effects	   might	   be	   adjusted	   to	   direct	   the	   fate	   of	  
encapsulated	  hASCs	  toward	  specific	  lineages.	  	  
Conclusions	  
We	  have	  developed	  in	  this	  study	  injectable	  PL	  nanocomposite	  
fibrillar	   hydrogels	   that	   are	   biochemically,	   mechanically	   and	  
structurally	   tunable,	   enabling	   the	   modulation	   of	   multiple	  
parameters	  of	   the	  3D	  cell	  microenvironment	   in	  ways	   that	  are	  
poorly	   achieved	   with	   other	   traditional	   polymer-­‐based	  
strategies.	   It	   is	   anticipated	   that	   this	   natural-­‐based	   hydrogel	  
platform	   will	   find	   multiple	   applications	   as	   a	   bioactive	   cell	  
carrier	  matrix	  capable	  of	  harnessing	  the	  regenerative	  potential	  
of	  platelets	  content	  and	  promote	  regenerative	  wound	  healing	  
outcomes	  in	  tissue	  engineering	  strategies.	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Scheme	  1.	  Schematic	  representation	  of	  the	  preparation	  of	  natural	   fibrillar	  nanocomposite	  hydrogels	   (PL-­‐CNC	  0-­‐
0.61).	   PL	   was	   obtained	   by	   freeze-­‐thaw	   cycles	   which	   allowed	   the	   release	   of	   platelets	   content	   (A).	   CNC	   were	  
modified	   with	   aldehyde	   groups	   by	   periodate	   oxidation	   (B).	   Injectable	   fibrillar	   nanocomposite	   hydrogels	   were	  
prepared	   using	   fibrin	   polymerization	   (coagulation	   cascade	   induction)	   and	   covalent	   crosslinking	   between	  
aldehydes	  on	  CNC	  surface	  and	  amine	  groups	  of	  PL	  proteins	  (Schiff’s	  base	  reaction)	  (C).	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Figure	   1.	   Microstructure	   of	   PL	   and	   nanocomposite	   fibrillar	   hydrogels.	   Maximum	   intensity	   projection	   (10	   µm	  
height	   stack)	   and	   3D	   view	   of	   Alexa	   Fluor	   488	   conjugated	   fibrinogen	   showing	   fibrin	   polymerized	   network	   (A).	  
Percent	  of	  porosity	  of	  a	  4	  µm	  thick	  section	  of	   fluorescent	  confocal	   images	  (B).	  Fiber	  diameter	  determined	  from	  
SEM	  images	  (C).	  Microstructural	  analysis	  by	  SEM	  (D).	  *	  PL-­‐CNC	  0	  vs	  PL-­‐CNC	  (0.15-­‐0.61);	  +	  PL-­‐CNC	  0.15	  vs	  PL-­‐CNC	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Figure	  2.	  Physical	  characterization	  of	  nanocomposite	  hydrogels.	  Storage	  modulus	  (G’)	  versus	  polymerization	  and	  
crosslinking	  time	  at	  1%	  strain	  and	  frequency	  of	  1	  Hz	  (A).	  Storage	  modulus	  (G’)	  of	  PL/CNC	  hydrogels	  averaged	  from	  
the	   frequency-­‐sweep	   measurements	   between	   0.1	   to	   1	   Hz	   at	   0.5%	   strain	   (B).	   Representative	   images	   of	   AFM-­‐
generated	   height	   (top)	   and	   Young’s	   modulus	   (YM)	   (bottom)	   for	   PL-­‐CNC	   hydrogels	   conditions	   (C)	   and	   Average	  
Young’s	  modulus	   for	   hydrogels	   (all	   image)	   and	   fibrils	   in	   each	   PL-­‐CNC	   formulation	   (D).	  Weight	   loss	   over	   7	   days	  
immersed	   in	  PBS	   (E).	  Cumulative	  concentration	   release	  of	  PDGF-­‐BB	   in	   cell	   culture	  medium	   (F).	  Western	  Blot	  of	  
PDGF-­‐BB	  within	  natural	  fibrillar	  hydrogels	  at	  day	  5	  in	  cell	  culture	  medium	  (G).	  	  ___	  between	  selected	  conditions,	  *	  
PL-­‐CNC	  0	  vs	  PL-­‐CNC	   (0.15-­‐0.61);	  +	  PL-­‐CNC	  0.15	  vs	  PL-­‐CNC	   (0.46-­‐0.61);	  #	  PL-­‐CNC	  0.15	  vs	  PL-­‐CNC	  0.61;	  &	  PL-­‐CNC	  
0.31	  vs	  PL-­‐CNC	  0.61;	  $	  PL-­‐CNC	  0.46	  vs	  PL-­‐CNC	  0.61.	  Hydrogel	  rigidity:	  ε	  PL-­‐CNC	  0	  vs	  PL-­‐CNC	  0.61;	  δ	  PL-­‐CNC	  0.15	  vs	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PL-­‐CNC	  0.61;	  Fiber	  rigidity:	  β	  PL-­‐CNC	  0	  vs	  PL-­‐CNC	  0.61;	  #	  PL-­‐CNC	  0.15	  vs	  PL-­‐CNC	  0.61;	  &	  PL-­‐CNC	  0.31	  vs	  PL-­‐CNC	  





Figure 3. In vitro evaluation of cell supportive properties and hydrogels retraction upon cell 
encapsulation. Live/Dead staining with Calcein AM/PI (green: live cell; red: dead cell) of hASCs 
encapsulated in PL/CNC hydrogels (A). Metabolic activity normalized by total DNA content (B). 
Photographs of PL-CNC hydrogels after 3 hours and 7 days in culture (C). Hydrogels diameter 
retraction in percentage at 1, 4 and 7 days – statistically differences in all formulations, except PL-CNC 
0.31 vs PL-CNC 0.46 at time point 1 (D). * PL-CNC 0 vs PL-CNC (0.15-0.61); & PL-CNC 0.31 vs PL-
CNC 0.61 and $ PL-CNC 0.61 vs PL-CNC 0.15. Scale bars: 75 µm (A) and 4 mm (C). 
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Figure 4. In vitro evaluation of cellular differentiation in PL and PL-CNC hydrogels. Fluorescence 
microscopy images showing cytoskeleton organization in the fibrin matrix after 1 day in culture (A). Cell 
axial ratio and cell spreading area after 1 day of culture were quantified for all conditions (B). 
Fluorescence microscopy images showing cytoskeleton organization after 1 and 3 days in culture (C). 
Cell axial ratio and cell spreading area after 1 and 3 days of culture were quantified for PL-CNC 0.61 
(D). Collagen Type III deposition after 8 days in culture. Staining fibrinogen (green) (A), collagen Type 
III (green) (E), actin (red) and nuclei (blue) (A, C and E). Scale bars: 10 µm (A) and 50 µm (C).  ___ 
between selected conditions; λ PL-CNC 0 vs PL -CNC (0.15-0.46); & PL-CNC 0.31 vs PL -CNC 0.61 and 
$ PL-CNC 0.46 vs PL -CNC 0.61. 
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Figure 5. hASCs were assessed for the expression of chondrogenic (SOX-9 and COMP), osteogenic 
(RUNX2, COLA1 and ALP), adipogenic (LPL and PPARγ), tenogenic (MKX), anti-morphogenic (PDGF) 
and angiogenic markers (VEGF) (A). ALP activity was quantified after 9 days in culture (B). Runt-related 
transcription factor 2 (RUNX2), SRY-box 9 (SOX9), Mohawk (MKX), collagen type I alpha 1 chain 
(COLA1), cartilage oligomeric matrix protein (COMP), platelet-derived growth factor-B (PDGF), 
peroxisome proliferator-activated receptor γ (PPARγ), lipoprotein lipase (LPL), leptin (LEP), vascular 
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Scheme	   2.	   Schematic	   representation	   of	   the	   cytoskeletal	   organization	   of	   encapsulated	   hASCs	   in	   function	   of	   PL	  
nanocomposite	   hydrogel	   composition	   and	   stiffness	   (A).	   Influence	   of	   each	   studied	   parameter	   in	   the	   hydrogel	  
physical	  properties	  and	  cell	  behavior	  (B).	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